| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research And Development
1 company
Stahl Neil is an EVP Research And Development at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 56 sells.
Estimated insider holdings value: $29.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2019 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sell | 7,364 | $338.52 | $2,492,887.72 | -2.7% | |
| May 14, 2019 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 9,853 | $305.74 | $3,012,483.11 | -17.0% | |
| May 24, 2018 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 11,407 | $295.09 | $3,366,091.63 | -26.3% | |
| Jun 22, 2017 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 8,306 | $532.55 | $4,423,331.53 | -1.5% | |
| Jun 15, 2017 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 8,567 | $468.45 | $4,013,176.94 | -2.5% | |
| Jun 2, 2017 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 2,812 | $479.49 | $1,348,313.67 | -0.9% |